FLCCC - Ivermectin vs Merck's new early treatment drug

Newsmax's Host Eric Bolling interviews Dr. Pierre Kory about Ivermectin and Merck's new drug.

Donate to the Front Line Covid-19 Critical Care Alliance, Inc
To educate medical professionals and the public in safe and effective ways to prevent and treat COVID-19.

Click here to make a donation:
https://covid19criticalcare.com/network-support/support-our-work/
GoFundMe: https://charity.gofundme.com/donate/project/front-line-covid-19-critical-care-alliance/joyce-kamen
Buy FLCCC gear at:
https://theflcccstore.org/
Subscribe to our mailing list on our website: http://flccc.net/signup
Follow us on Telegram: https://t.me/FLCCC_Alliance

Source: https://odysee.com/@FrontlineCovid19CriticalCareAlliance:c/ERIC-BOLLING-THE-BALANCE-KORY-Oct-1-2021:c
Publication date: October 2nd, 2021